These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 18557587)
21. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A. Glaser DA J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745 [TBL] [Abstract][Full Text] [Related]
22. [Focal hyperhidrosis: disease characteristics and treatments]. Campanelli A; Salomon D Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086 [TBL] [Abstract][Full Text] [Related]
23. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A. Coutinho dos Santos LH; Gomes AM; Giraldi S; Abagge KT; Marinoni LP Pediatr Dermatol; 2009; 26(4):439-44. PubMed ID: 19689521 [TBL] [Abstract][Full Text] [Related]
24. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Kreyden OP; Scheidegger EP Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544 [TBL] [Abstract][Full Text] [Related]
25. Clinical differentiation of primary from secondary hyperhidrosis. Walling HW J Am Acad Dermatol; 2011 Apr; 64(4):690-5. PubMed ID: 21334095 [TBL] [Abstract][Full Text] [Related]
26. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Solish N; Benohanian A; Kowalski JW; Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315 [TBL] [Abstract][Full Text] [Related]
27. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis. Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233 [TBL] [Abstract][Full Text] [Related]
28. Impact of hyperhidrosis on quality of life and its assessment. Hamm H Dermatol Clin; 2014 Oct; 32(4):467-76. PubMed ID: 25152339 [TBL] [Abstract][Full Text] [Related]
29. Type A botulinum toxin: a new treatment for axillary and palmar hyperhidrosis. Rusciani L; Severino E; Rusciani A J Drugs Dermatol; 2002 Sep; 1(2):147-51. PubMed ID: 12847738 [TBL] [Abstract][Full Text] [Related]
30. [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections]. Kreyden OP; Böni R; Burg G Praxis (Bern 1994); 2000 May; 89(21):909-15. PubMed ID: 10859980 [TBL] [Abstract][Full Text] [Related]
33. Localized hyperhidrosis in pretibial myxedema. Gitter DG; Sato K J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):250-4. PubMed ID: 2212121 [TBL] [Abstract][Full Text] [Related]
34. Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis. Bechara FG; Sand M; Hoffmann K; Boorboor P; Altmeyer P; Stuecker M Dermatol Surg; 2008 Aug; 34(8):1001-9; discussion 1009. PubMed ID: 18430175 [TBL] [Abstract][Full Text] [Related]
35. [Video-thoracoscopic sympathectomy in the treatment of Raynaud's disease and palmar hyperhidrosis]. Trignano M; Boatto R; Mastino GP; Ferrandu T; Padula G; Loi V; Pala C Minerva Chir; 2000; 55(1-2):17-23. PubMed ID: 10832279 [TBL] [Abstract][Full Text] [Related]
36. Hyperhidrosis: an approach to diagnosis and management. Haider A; Solish N Dermatol Nurs; 2004 Dec; 16(6):515-7, 523. PubMed ID: 15690929 [TBL] [Abstract][Full Text] [Related]
37. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649 [TBL] [Abstract][Full Text] [Related]